Virtus ETF Advisers’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,426
| Closed | -$336K | – | 280 |
|
|
2024
Q4 | $336K | Sell |
1,426
-632
| -31% | -$149K | 0.14% | 221 |
|
|
2024
Q3 | $566K | Hold |
2,058
| – | – | 0.26% | 180 |
|
|
2024
Q2 | $500K | Buy |
2,058
+15
| +0.7% | +$3.65K | 0.24% | 179 |
|
|
2024
Q1 | $305K | Buy |
2,043
+294
| +17% | +$43.9K | 0.16% | 226 |
|
|
2023
Q4 | $335K | Buy |
1,749
+216
| +14% | +$41.3K | 0.21% | 200 |
|
|
2023
Q3 | $271K | Sell |
1,533
-198
| -11% | -$35.1K | 0.16% | 214 |
|
|
2023
Q2 | $329K | Buy |
1,731
+414
| +31% | +$78.6K | 0.19% | 178 |
|
|
2023
Q1 | $264K | Buy |
1,317
+24
| +2% | +$4.81K | 0.15% | 269 |
|
|
2022
Q4 | $307K | Sell |
1,293
-468
| -27% | -$111K | 0.16% | 254 |
|
|
2022
Q3 | $352K | Buy |
1,761
+23
| +1% | +$4.6K | 0.14% | 255 |
|
|
2022
Q2 | $253K | Sell |
1,738
-265
| -13% | -$38.6K | 0.09% | 295 |
|
|
2022
Q1 | $327K | Hold |
2,003
| – | – | 0.15% | 169 |
|
|
2021
Q4 | $340K | Sell |
2,003
-742
| -27% | -$126K | 0.13% | 185 |
|
|
2021
Q3 | $518K | Sell |
2,745
-251
| -8% | -$47.4K | 0.23% | 132 |
|
|
2021
Q2 | $508K | Sell |
2,996
-1,725
| -37% | -$292K | 0.21% | 141 |
|
|
2021
Q1 | $667K | Buy |
4,721
+134
| +3% | +$18.9K | 0.28% | 113 |
|
|
2020
Q4 | $596K | Sell |
4,587
-75
| -2% | -$9.75K | 0.25% | 116 |
|
|
2020
Q3 | $679K | Buy |
4,662
+393
| +9% | +$57.2K | 0.36% | 110 |
|
|
2020
Q2 | $632K | Sell |
4,269
-733
| -15% | -$109K | 0.3% | 103 |
|
|
2020
Q1 | $544K | Sell |
5,002
-422
| -8% | -$45.9K | 0.22% | 166 |
|
|
2019
Q4 | $625K | Sell |
5,424
-4,464
| -45% | -$514K | 0.1% | 182 |
|
|
2019
Q3 | $795K | Sell |
9,888
-1,671
| -14% | -$134K | 0.16% | 155 |
|
|
2019
Q2 | $839K | Buy |
11,559
+1,297
| +13% | +$94.1K | 0.18% | 174 |
|
|
2019
Q1 | $959K | Buy |
10,262
+2,399
| +31% | +$224K | 2.04% | 10 |
|
|
2018
Q4 | $573K | Buy |
7,863
+3,436
| +78% | +$250K | 0.1% | 58 |
|
|
2018
Q3 | $387K | Sell |
4,427
-3,154
| -42% | -$276K | 0.04% | 165 |
|
|
2018
Q2 | $747K | Buy |
7,581
+1,529
| +25% | +$151K | 0.66% | 72 |
|
|
2018
Q1 | $721K | Buy |
6,052
+3,277
| +118% | +$390K | 0.63% | 91 |
|
|
2017
Q4 | $353K | Sell |
2,775
-1,636
| -37% | -$208K | 0.44% | 84 |
|
|
2017
Q3 | $518K | Buy |
4,411
+404
| +10% | +$47.4K | 0.07% | 86 |
|
|
2017
Q2 | $320K | Sell |
4,007
-2,471
| -38% | -$197K | 0.05% | 107 |
|
|
2017
Q1 | $332K | Buy |
6,478
+621
| +11% | +$31.8K | 0.06% | 129 |
|
|
2016
Q4 | $219K | Buy |
5,857
+1,779
| +44% | +$66.5K | 0.07% | 169 |
|
|
2016
Q3 | $276K | Hold |
4,078
| – | – | 0.13% | 107 |
|
|
2016
Q2 | $226K | Buy |
4,078
+1,279
| +46% | +$70.9K | 0.17% | 118 |
|
|
2016
Q1 | $176K | Buy |
+2,799
| New | +$176K | 0.24% | 102 |
|